Mozambique

in page functions
[French]
Mozambique
Total population (2018) 30,338,918
Birth cohort (2018) 1,141,595
Surviving Infants (surviving to 1 year per year, 2018) 1,077,629
Infant mortality rate (deaths < 1 year per 1000 births, 2015) 57/1000
Child mortality rate (deaths < 5 years per 1000 births, 2015) 79/1000
World Bank Index, IDA (2015) 3.48
Gross Nation Income (per capita US$, 2015) 590
No. of districts/territories (2017) 161

Contact Gavi

For more info, contact Gavi country representative officer or email here

Gavi support for Mozambique

Type of support

Approvals

2001-2023 (US$)
(2 Jul 2019)

Commitments

2001-2023 (US$)
(2 Jul 2019)

Disbursements

2000-2019 (US$)
(2 Jul 2019)

% Disbursed

(2 Jul 2019)
2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021
Total $244,878,557 $250,227,044 $257,391,237
Cash Support (CASHSUPP) $170,000 $170,000 $170,000 100%
Cold Chain Equipment Optimisation Platform (CCEOP) $4,577,948 $5,128,062
Health system strengthening (HSS 1) $24,392,121 $29,190,494 $22,373,683 92%
HPV Demo (NVS) $56,503 $56,503 $56,503 100%
Immunisation services support (ISS) $1,665,500 $1,665,500 $1,665,500 100%
Injection Safety Devices (NVS) $1,925,969 $1,925,969 $2,163,506 112%
Injection safety support (INS) $835,881 $835,881 $835,881 100%
IPV (NVS) $9,911,927 $9,911,927 $8,208,738 83%
Measles (NVS) $1,077,756 $1,077,756 $1,077,756 100%
MR 1st and 2nd dose (NVS) $566,000 $566,000 $582,064 103%
MR 1st dose (NVS) $721,500 $721,500 $730,295 101%
MR-Catch-up campaign (NVS) $9,499,000 $9,499,000 $9,742,824 103%
MR-Catch-up campaign op.costs (OPC) $7,935,500 $7,935,500 $7,879,866 99%
Penta (NVS) $47,512,655 $47,512,655 $47,104,025 99%
Pneumo (NVS) $94,938,411 $94,938,411 $116,465,686 123%
Product Switch Grant (PSG) $292,000 $292,000 $271,286 93%
Rotavirus (NVS) $19,852,174 $19,852,174 $19,115,912 96%
Tetra DTP-HepB (NVS) $16,897,320 $16,897,320 $16,897,320 100%
Vaccine Introduction Grant (VIG) $2,050,392 $2,050,392 $2,050,392 100%

Red line on table indicates duration of support based on commitments.
Commitments: Multi-year programme budgets endorsed in principle by the Gavi Board. These become financial commitments upon approval each year for the following calendar year.
Approvals: Total Approved for funding

Download data for commitments, approvals & disbursements in XLS format

Mozambique DTP3 / immunisation coverage

DTP3 - WHO/UNICEF estimates (2017)

Grade of confidence


N/A
DTP3 - Official country estimates (2017) 99%
M:F sex ratio at birth (2018) 1.03
Household survey: DTP3 coverage for male (2010) 76.20%
Household survey: DTP3 coverage for female (2010) 76.10%
Household survey: Last DTP3 survey (2010) 76%
% districts achieving > 80% DTP3 coverage (2017) 91%
% districts achieving < 50% DTP3 coverage (2017) 1%
MCV WHO/UNICEF estimates (2017) 85%

Breakdown of support

Non-vaccine support Vaccine support
14% 86%
$35,246,608 $222,144,629

Data refers to disbursed values, date as per above chart

Move mouse over graph for details

News and updates relating to Mozambique

27 May 2019

DRC cholera vaccine

Major cholera vaccination campaign begins in North Kivu in the Democratic Republic of the Congo

Agencies warn of unprecedented situation in the DRC as cholera and measles epidemics compound Ebola challenges.

03 April 2019

mozambique

Cholera vaccination campaign begins in Mozambique

Following Cyclone Idai devastation, nearly 900,000 people will receive the vaccine from the Gavi-funded stockpile.

27 March 2019

Gavi item

Leadership training for supply chain managers expands to five African countries

Over 22 private sector partners will support the innovative training and mentorship programme.

Disclaimer: the boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of Gavi, the Vaccine Alliance concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement.

close icon

modal window here